United States — United States Securities and Exchange Commission & Guggenheim Partners
21 shared events · Importance 7 · Last updated Aug 20, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States — United States Securities and Exchange Commission: The SEC declared the registration statements effective, enabling the IPO to proceed. This regulatory action is routine but essential for the offering's completion.
Guggenheim Partners: Guggenheim Partners acted as a lead book-running manager, earning fees and demonstrating its capability in executing biotech IPOs. The successful offering supports its investment banking business.
Aug 07, 2026 · 8 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared the registration statement for BHAV Acquisition Corp's IPO effective, fulfilling its regulatory oversight role.
Guggenheim Partners: Guggenheim Partners acted as the sole book-running manager for the IPO of BHAV Acquisition Corp, facilitating the offering and demonstrating its role in capital markets.
Apr 16, 2026 · 6 articles
Business
United States — United States Securities and Exchange Commission: The SEC declared the shelf registration statement effective, enabling the offering. It oversees the disclosure and compliance aspects of the transaction.
Guggenheim Partners: Guggenheim Partners is the sole book-running manager for the offering, earning underwriting fees and strengthening its relationship with Edesa.
Aug 19, 2026 · 12 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared Eric Rock's registration statement on Form S-1 effective, allowing the IPO to proceed.
Guggenheim Partners: Guggenheim Securities is acting as a bookrunner for Eric Rock's IPO.
Jun 01, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: The SEC is the regulator reviewing Jersey Mike s Subs registration statement; the IPO cannot proceed until the registration becomes effective.
Guggenheim Partners: Guggenheim Securities is a co-global coordinator and joint bookrunner, involved in the IPO.
Jul 20, 2026 · 6 articles
Business
United States — United States Securities and Exchange Commission: The SEC reviewed and declared effective Scribe's registration statement, enabling the IPO. Its regulatory oversight is a standard part of the process.
Guggenheim Partners: Guggenheim Partners acted as a joint book-running manager, earning underwriting fees.
Jul 06, 2026 · 25 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared effective the Registration Statement on Form S-3 for Forte Biosciences's public offering.
Guggenheim Partners: Guggenheim Partners is acting as a book-running manager for the public offering by Forte Biosciences.
Apr 08, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: The SEC oversees the registration and prospectus filing for the offering, ensuring regulatory compliance.
Guggenheim Partners: Guggenheim Partners is a joint book-running manager, participating in the offering and earning fees.
Aug 04, 2026 · 6 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared the registration statement for Sophia Genetics's offering effective, ensuring regulatory compliance.
Guggenheim Partners: Guggenheim Partners is acting as a book-running manager for the public offering by Sophia Genetics.
Jun 16, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: The SEC is the regulatory body reviewing Holtec's registration statement; the offering cannot proceed until the statement becomes effective.
Guggenheim Partners: Guggenheim Securities is a joint lead book-running manager for the offering.
Apr 20, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: The SEC is the regulatory body that received the Form 4 filings disclosing the CEO's stock sales, ensuring transparency.
Guggenheim Partners: Guggenheim Partners initiated coverage with a Buy rating and a $180 price target, highlighting Guidewire's strong position in the P&C insurance sector.
Jul 14, 2026 · 6 articles
Business
United States — United States Securities and Exchange Commission: Neurogene filed a shelf registration statement with the United States — United States Securities and Exchange Commission, which was declared effective, enabling the public offering.
Guggenheim Partners: Guggenheim Partners is acting as a joint bookrunning manager for Neurogene's public offering.
Jun 30, 2026 · 6 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission received registration statements for the offering, ensuring regulatory compliance.
Guggenheim Partners: Guggenheim Partners is acting as an active book-running manager for the initial public offering of Parabilis Medicines.
Jun 10, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: The SEC declared Reformation's registration statement effective, enabling the IPO to proceed.
Guggenheim Partners: Guggenheim Securities acted as additional bookrunning manager, earning underwriting fees.
Jul 20, 2026 · 19 articles
Business
United States — United States Securities and Exchange Commission: The SEC declared the shelf registration statement effective on July 10, 2026, enabling the offering.
Guggenheim Partners: Guggenheim Securities acted as joint book-running manager for the offering, earning underwriting fees.
Jul 14, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: The SEC received Form 4 filings disclosing the insider transactions, ensuring regulatory compliance.
Guggenheim Partners: Guggenheim increased its price target to $300, citing positive growth outlook and early adoption of Bits AI.
Jul 28, 2026 · 6 articles
Business
United States — United States Securities and Exchange Commission: The SEC received the Form 4 filings for the transactions; the event is routine and does not affect the SEC.
Guggenheim Partners: Guggenheim raised its price target to $300, citing strong revenue growth expectations and early adoption of Bits AI.
Jul 17, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared the Registration Statement on Form S-1 effective for the offering.
Guggenheim Partners: Guggenheim Partners acted as a bookrunner for the offering.
Apr 06, 2026 · 8 articles
Business
United States — United States Securities and Exchange Commission: The SEC oversees the offering through its shelf registration process, ensuring regulatory compliance.
Guggenheim Partners: Guggenheim Partners acts as a joint bookrunner, earning underwriting fees.
Aug 13, 2026 · 6 articles
Business
Guggenheim Partners: Guggenheim Partners is acting as a joint book-running manager for the public offering of Spyre Therapeutics' common stock.
Apr 13, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — United States Securities and Exchange Commission and Guggenheim Partners interact across events, view sentiment trends, and discover connected entities.
Open Dashboard